Terazosin Hydrochloride

This page contains recent news articles, when available, and an overview of Terazosin Hydrochloride but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

Terazosin Hydrochloride
(when available)

Pharmacology and use:
Terazosin, classified as a quinazoline, is similar to doxazosin and prazosin. As an alpha-adrenergic blocking agent, terazosin is used to treat hypertension and benign prostatic hypertrophy (BPH). Terazosin produces vasodilation and reduces peripheral resistance but in general has slight effect on cardiac output. Antihypertensive effect with chronic dosing is usually not accompanied by reflex tachycardia. For the treatment of symptomatic benign prostatic hyperplasia (BPH) and also for hypertension.

Mechanism Of Action:
Terazosin selectively and competitively inhibits vascular postsynaptic alpha(1)-adrenergic receptors, resulting in peripheral vasodilation and a reduction of vascular resistance and blood pressure. Unlike the nonselective alph-adrenergic blockers phenoxybenzamine and phentolamine, terazosin does not block presynaptic alpha(2)-receptors and, hence, does not cause reflex activation of norepinephrine release to produce reflex tachycardia.

News Articles on Terazosin

IN RE TERAZOSIN HYDROCHLORIDE ANTITRUST LITIGATION, 352 F. …  -  Jan 5, 2005
Supreme Court Cases - Research for US Supreme Court Cases, Federal Circuit Court Cases, and Federal District Court Cases. Whether you need decisions in ... $2.95 - U.S. District Courts - VersusLaw

IN RE TERAZOSIN HYDROCHLORIDE ANTITRUST LITIGATION, 99- …  -  Jul 8, 2005
IN RE: TERAZOSIN HYDROCHLORIDE ANTITRUST LITIGATION. THIS DOCUMENT RELATES TO: United Wisconsin Services, Inc., et al. Abbott Laboratories, ND Ill. CA No. ... $2.95 - U.S. District Courts - VersusLaw

… Federal District Court Opinions - IN RE TERAZOSIN HYDROCHLORIDE …  -  Jan 5, 2005
IN RE TERAZOSIN HYDROCHLORIDE ANTITRUST LITIGATION (S.D.Fla. 2005). 352 F. Supp.2d 1279 ... Id. Geneva filed two ANDAs for terazosin hydrochloride. ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw

… Federal District Court Opinions - IN RE TERAZOSIN HYDROCHLORIDE …  -  Jul 8, 2005
IN RE TERAZOSIN HYDROCHLORIDE ANTITRUST LITIGATION (SDFla. 2005) IN RE: TERAZOSIN HYDROCHLORIDE ANTITRUST LITIGATION. THIS DOCUMENT RELATES TO: United ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw

Generic name: Terazosin hydrochloride  -  Dec 1, 2005
Hytrin is prescribed to reduce high blood pressure. It may be used alone or in combination with other blood pressure lowering drugs, such as HydroDIURIL (a ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com

Comorbid conditions in men with ED before and after ED diagnosis: a …  -  Sep 1, 2005
Classification codes for doxazosin mesylate, dutasteride, finasteride, tamsulosin hydrochloride, terazosin hydrochloride and alfuzosin hydrochloride. ... Nature.com

Phenoxybenzamine Oral: Dosage, Uses and Warnings  -  Oct 17, 2006
Hytrin (terazosin hydrochloride) US prescribing information. Abbott Laboratories February, 2006. 14.Kloner RA, Jackson G, Emmick JT, Mitchell MI, Bedding A, ... Medscape

Woodard v. Fidelity National Title Insurance Co., No. CIV 06-1170 RB/...  -  Dec 4, 2007
Defendant also asks the Court to rely on a district court case, In re Terazosin Hydrochloride Antitrust Litigation, which instructs that "a claim cannot be ... $2.95 - U.S. District Court, District of New... - VersusLaw

United States 11th Circuit Court of Appeals Reports - SCHERING- …  -  Mar 8, 2005
See In re Terazosin Hydrochloride Antitrust Litig., 164 F.Supp.2d 1340 (SDFla. 2000). We reversed that decision, and concluded that monetary payments made ... Pay-Per-View - United States 11th Circuit Court of... - Loislaw

Schering-Plough Corp. v. Federal Trade Commission, 402 F.3d 1056, 74 ...  -  Mar 8, 2005
See In re Terazosin Hydrochloride Antitrust Litig., 164 F.Supp.2d 1340 (S.D. Fla. 2000). We reversed that decision, and concluded that monetary payments ... $2.95 - U.S. Court of Appeals, Eleventh Circuit - VersusLaw

China Government Cited in Medicine Probe  -  Feb 9, 2007
But he said that in a separate case, involving the high-blood-pressure drug terazosin hydrochloride, the company probably used another sample from outside ... Subscription - Wall Street Journal Online - Dow Jones & Company

Drug Makers Cleared on Delaying Generic  -  Apr 24, 2006
...which Geneva -- now Sandoz Inc., a subsidiary of Novartis AG -- delayed marketing its generic version of Abbott's terazosin hydrochloride drug, Hytrin. ... Law.com

Article: FDA approves Xyntha.(RX: RETAIL PHARMACY: Branded Drugs)( …  -  Mar 17, 2008
Mylan Laboratories Inc. received final clearance to manufacture and market terazosin hydrochloride capsules in 1-, 2-, 5- and 10-mg. strengths. ... Pay-Per-View - Chain Drug Review - HighBeam Research

Rosen v. Jeld-Wen, Inc., No. 07-22328-CIV-DIMITROULEAS/ …  -  Jun 12, 2008
In re Terazosin Hydrochloride, 220 F.R.D. 672, 687 (S.D. Fla. 2004); Agan v. Katzman & Korr, P.A., 222 F.R.D. 692, 697 (S.D. Fla. ... $2.95 - U.S. District Court, Southern District... - VersusLaw

Study Shows Treatment With Flomax(R) Results in More Rapid …  -  Jul 12, 2005
...associated with benign prostatic hyperplasia (enlarged prostate) than patients who received terazosin hydrochloride, after four days of treatment. ... RedOrbit

Abbott to close plant, cut 1,200 jobs Medical advances create market ...  -  Dec 5, 2007
Abbott stock closed down 25 cents at $35.25 Monday on the New York Stock Exchange. The drug ... terazosin hydrochloride. Abbott pointed to its patent for . ... Pay-Per-View - Daily Herald - HighBeam Research

FLORIDIANS WHO BOUGHT HYTRIN MAY GET REFUNDS TWO DRUG …  -  Apr 1, 2005
...to the settlement administrator: Terazosin Hydrochloride Antitrust Litigation, c/o Complete Claim Solutions Inc., P.O. Box 24607, West Palm Beach, Fla. ... Pay-Per-View - South Florida Sun - Sentinel - ProQuest Archiver

Article: More generic drugs ready for market.(RX/News) - Chain Drug …  -  Jan 31, 2005
...and bioequivalent to Glaxo Wellcome Inc ... solatol hydrochloride tablets in 80-, 120-, 160- and 240-mg. strengths and terazosin hydrochloride capsules. ... Pay-Per-View - Chain Drug Review - HighBeam Research

Loislaw Federal District Court Opinions - IN RE ALSTOM SA SECURITIES …  -  Aug 26, 2008
See In re Terazosin Hydrochloride Antitrust Litig., 220 F.R.D. 672 , 699 (S.D. Fla. 2004) ("[A]llocation will become an intra-class matter accomplished ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw

Davis v. Kraft Foods North America, No. 03-6060 (EDPa. 01/31/2006)  -  Jan 31, 2006
...or provide representation on the basis of the client's consent"); In Re Terazosin Hydrochloride Antitrust Litigation, 223 F.R.D. 666, (S.D. Fla. ... $2.95 - U.S. District Court, Eastern District... - VersusLaw

Kansans eligible for Hytrin settlement refund  -  May 28, 2005
Claims forms also can be obtained by calling the settlement administrator at 1 (877) 886-0283, or by writing to: In re Terazosin Hydrochloride Antitrust ... Topeka Capital-Journal - Topeka Capital Journal

Ohio State Reports - JOHNSON v. MICROSOFT CORP., 106 Ohio St.3d …  -  Oct 5, 2005
In addition, we are mindful of the court's concerns expressed in the case of In re Terazosin Hydrochloride Antitrust Litigation (SDFla. ... Pay-Per-View - Ohio State Reports - Loislaw

… GENERAL HATCH ANNOUNCES MINNESOTA CONSUMERS MAY FILE …  -  Jul 7, 2005
In re Terazosin Hydrochloride Antitrust Litigation c/o Complete Claim Solutions, Inc. PO Box 24607 West Palm Beach, FL 33416. Pay-Per-View - US Fed News - Factiva, from Dow Jones

Tennessee Reports - FREEMAN INDUSTRIES v. EASTMAN CHEMICAL …  -  Aug 25, 2005
See eg, In re Terazosin Hydrochloride Antitrust Litig., 160 F.Supp.2d 1365, 1378 (SDFla. 2001); FTC v. Mylan Labs., Inc., 99 F.Supp.2d 1, 4 (DC Cir. 1999). ... Pay-Per-View - Tennessee Reports - Loislaw

IN RE LUPRONĀ® MARKETING AND SALES PRACTICES LITIGATION, …  -  May 12, 2005
In re Terazosin Hydrochloride Antitrust Litig., 220 F.R.D. 672, 686 (S.D. Fla. 2004) (finding that representatives were typical of plaintiffs subject to an ... $2.95 - U.S. District Courts - VersusLaw

In re Tamoxifen Citrate Antitrust Litigation, 429 F.3d 370 (2d Cir....  -  Nov 2, 2005
...[42], Id. (distinguishing the Settlement Agreement from the agreements addressed in In re Terazosin Hydrochloride Antitrust Litig., 164 F. Supp. ... $2.95 - U.S. Court of Appeals, Second Circuit - VersusLaw

Brand Names/Synonyms:
Terazosin Hydrochloride is also known by the following brand names and/or synonymsAbbott 45975; Blavin; CHEMBANK1722; Flumarc; Fosfomic; Heitrin; Hytracin; Hytrin; Hytrinex; Itrin; Terazosin; Terazosin Hcl; Terazosin Hydrochloride; Terazosina [Inn-Spanish]; Terazosine; Terazosine [Inn-French]; Terazosinum [Inn-Latin]; Trazosin Hcl; Urodie; Vasocard; Vasomet; Vicard

Drug Category:
Terazosin Hydrochloride is categorized under the following by the FDA: Antineoplastic Agents; Adrenergic alpha-Antagonists; Platelet Aggregation Inhibitors; ATC:G04CA03

Dosage Forms:
TABLET

Absorption:
Essentially completely absorbed in man (90% bioavailability).

Interactions:
[an error occurred while processing this directive]



Chemical IUPAC Name:
[4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-tetrahydrofuran-2-yl-methanone





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy